PRESS RELEASE published on 04/23/2024 at 20:40, 1 year 9 months ago Evotec SE appoints Dr Christian Wojczewski as Chief Executive Officer Evotec SE appoints Dr Christian Wojczewski as Chief Executive Officer, effective 01 July 2024, following an extensive selection process. Dr Wojczewski brings over 20 years of management experience in the healthcare industry Healthcare Industry Evotec SE Chief Executive Officer Dr Christian Wojczewski Management Experience
PRESS RELEASE published on 04/23/2024 at 20:38, 1 year 9 months ago EQS-Adhoc: Evotec SE appoints Dr Christian Wojczewski as Chief Executive Officer Evotec SE appoints Dr Christian Wojczewski as Chief Executive Officer. Dr Wojczewski brings over 20 years of management experience, succeeding Dr Mario Polywka Evotec SE Chief Executive Officer Dr Christian Wojczewski Management Experience Dr Mario Polywka
BRIEF published on 04/18/2024 at 13:32, 1 year 9 months ago Evotec and Variant Bio Announce Strategic Partnership to Combat Fibrosis Strategic Partnership Evotec Variant Bio Fibrosis Treatment Genomic Discovery
PRESS RELEASE published on 04/18/2024 at 13:27, 1 year 9 months ago Evotec and Variant Bio enter strategic partnership to discover and develop fibrosis treatments Evotec SE and Variant Bio partner to discover and develop fibrosis treatments, leveraging cutting-edge genomic discovery platforms. Agreement includes research funding and milestone/royalty payments Evotec SE Research Funding Variant Bio Genomic Discovery Fibrosis Treatments
BRIEF published on 04/17/2024 at 15:05, 1 year 9 months ago Evotec SE Set to Announce 2023 Fiscal Year Results Financial Results Life Sciences Evotec SE Fiscal Year 2023 Stakeholder Engagement
PRESS RELEASE published on 04/17/2024 at 15:00, 1 year 9 months ago Evotec SE to announce results for fiscal year 2023 on 24 April 2024 Evotec SE will announce its financial results for 2023 with a conference call on 24 April 2024. The company focuses on developing therapeutics through a unique business model Financial Results Conference Call Evotec SE Therapeutics Business Model
BRIEF published on 04/17/2024 at 07:35, 1 year 9 months ago Evotec Appoints Aurélie Dalbiez as Chief People Officer Chief People Officer Human Resources Corporate Leadership Evotec Aurélie Dalbiez
PRESS RELEASE published on 04/17/2024 at 07:30, 1 year 9 months ago Evotec welcomes Aurélie Dalbiez as Chief People Officer Evotec SE appoints Aurélie Dalbiez as Chief People Officer, bringing extensive HR leadership experience to drive organizational transformation and employee engagement Chief People Officer Evotec SE Human Resources Aurélie Dalbiez Organizational Transformation
BRIEF published on 03/06/2024 at 07:35, 1 year 10 months ago Evotec and Claris Ventures Partner to Accelerate Biotech Clinical Programs Evotec SE Claris Ventures Biotech Clinical Development IAMA Therapeutics Drug Development Partnership
PRESS RELEASE published on 03/06/2024 at 07:30, 1 year 10 months ago Evotec and Claris Ventures streamline access to accelerate programmes from Claris's portfolio companies into the clinic Evotec and Claris Ventures streamline access to accelerate programmes from Claris's portfolio companies into the clinic. Evotec and Claris announce acceleration framework to support biotech companies with clinical trials Clinical Trials Claris Ventures Evotec Acceleration Framework Biotech Companies
Published on 01/31/2026 at 03:15, 3 hours 12 minutes ago Empress Royalty Announces Grant Of Restricted Share Units
Published on 01/31/2026 at 02:20, 4 hours 7 minutes ago Boron One Announces First Closing of Financing
Published on 01/31/2026 at 01:40, 4 hours 47 minutes ago Star Copper Announces Grant of RSUs, Stock Options and PSUs
Published on 01/30/2026 at 23:00, 7 hours 27 minutes ago Avidian Gold Corp. Announces Director Resignation
Published on 01/31/2026 at 02:45, 3 hours 41 minutes ago CANADA BACKS NEW DEFENCE, SECURITY AND RESILIENCE BANK
Published on 01/30/2026 at 22:00, 8 hours 27 minutes ago Nebius Group N.V. announces date of fourth quarter and full year 2025 results and conference call
Published on 01/30/2026 at 20:10, 10 hours 16 minutes ago Cynosure Lutronic Announces Completion of EU MDR Approval and Global Momentum for Mosaic 3D™ Ahead of IMCAS 2026
Published on 01/30/2026 at 20:09, 10 hours 17 minutes ago Aroundtown SA successfully issued AUD 600 million bonds in two tranches
Published on 01/30/2026 at 20:07, 10 hours 19 minutes ago Aroundtown SA successfully issued AUD 600 million bonds in two tranches
Published on 01/30/2026 at 17:45, 12 hours 42 minutes ago Schneider Electric launches a capital increase reserved for employees
Published on 01/29/2026 at 18:00, 1 day 12 hours ago GUILLEMOT CORPORATION: FULL-YEAR 2025 CONSOLIDATED TURNOVER UP 2%
Published on 01/29/2026 at 17:45, 1 day 12 hours ago LANSON-BCC ANNOUNCES 2025 REVENUES AND FINALISES THE ACQUISITION OF HEIDSIECK & C° MONOPOLE
Published on 01/29/2026 at 17:45, 1 day 12 hours ago Cegedim generated LFL revenue growth of 1.1% in 2025